Bioprinting, once hailed for its potential to print human organs and tissues, took a backseat after the pandemic. However, with an estimated market value of $1.44...
Based in Granada, Regemat 3D is one of the main players in this new industry. The company manufactures tissue and organ biofabrication systems, bioprinters, and bioreactors,...